Navellier & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$12.3M |
| 2 |
First Trust Financials AlphaDEX Fund
FXO
|
+$12.2M |
| 3 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$12M |
| 4 |
Paycom
PAYC
|
+$6.81M |
| 5 |
VMW
VMware, Inc
VMW
|
+$6.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$19.2M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$12.8M |
| 3 |
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
|
+$7.66M |
| 4 |
First Trust NASDAQ-100 Technology Index Fund
QTEC
|
+$7.52M |
| 5 |
First Trust Technology AlphaDEX Fund
FXL
|
+$7.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.62% |
| 2 | Consumer Discretionary | 12.13% |
| 3 | Industrials | 11.05% |
| 4 | Healthcare | 8.71% |
| 5 | Financials | 6.69% |
Similar funds
Navellier & Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Navellier & Associates held 301 positions worth $647M, up 0.39% from $644M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Navellier & Associates withdrew a net $26.7M in Q2 2019, closing 30 positions and reducing 115 holdings. Its most notable exit was First Trust NYSE Arca Biotechnology Index Fund, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Navellier & Associates opened a new position in First Trust Consumer Discretionary AlphaDEX Fund worth $12.3M.
- Navellier & Associates's largest Q2 2019 buy was First Trust Consumer Discretionary AlphaDEX Fund: 287,544 shares worth $12.3M.
- Navellier & Associates added most to Paycom in Q2 2019, an estimated $6.81M increase.
- Navellier & Associates's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $12.8M.
- Navellier & Associates fully exited First Trust NYSE Arca Biotechnology Index Fund in Q2 2019, selling an estimated $19.2M.
- Navellier & Associates's ten largest holdings make up 28% of its $647M portfolio in Q2 2019.
- Navellier & Associates opened 59 new positions and closed 30 in Q2 2019.
- Navellier & Associates's portfolio value rose 0.39% quarter-over-quarter to $647M.
Based on Navellier & Associates's 13F filing for Q2 2019, filed 17 Jul 2019.